11/09 – Unicef: number of obese children exceeds that of malnourished children for the 1st time
In Brazil, the rate of obese children and adolescents has skyrocketed in the last 25 years, rising from 5% to 15%
09/09 – Without Wegovy in the SUS: why there is no medicine for obesity in public health
Brazil has six anti-obesity medications approved by Anvisa: sibutramine, orlistat, the combination of bupropion and naltrexone, liraglutide, semaglutide and tirzepatide. However, none are offered by the SUS
